J 2011

No evidence for linkage between the hereditary angiooedema clinical phenotype and the BDKR1, BDKR2, ACE or MBL2 gene.

FREIBERGER, Tomáš, Hana GROMBIŘÍKOVÁ, Barbora RAVČUKOVÁ, Jiří JARKOVSKÝ, Pavel KUKLÍNEK et. al.

Basic information

Original name

No evidence for linkage between the hereditary angiooedema clinical phenotype and the BDKR1, BDKR2, ACE or MBL2 gene.

Authors

FREIBERGER, Tomáš (203 Czech Republic, guarantor, belonging to the institution), Hana GROMBIŘÍKOVÁ (203 Czech Republic), Barbora RAVČUKOVÁ (203 Czech Republic), Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution), Pavel KUKLÍNEK (203 Czech Republic, belonging to the institution), Olga KRYŠTŮFKOVÁ (203 Czech Republic), Jana HANZLÍKOVÁ (203 Czech Republic), Eva DAŇKOVÁ (203 Czech Republic), Otakar KOPECKÝ (203 Czech Republic), Radana ZACHOVÁ (203 Czech Republic), Marie LAHODNÁ (203 Czech Republic), Martina VAŠÁKOVÁ (203 Czech Republic), Lucie GRODECKÁ (203 Czech Republic) and Jiří LITZMAN (203 Czech Republic, belonging to the institution)

Edition

Scandinavian journal of immunology, 2011, 0300-9475

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30102 Immunology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 2.230

RIV identification code

RIV/00216224:14110/11:00054430

Organization unit

Faculty of Medicine

UT WoS

000292254900013

Keywords in English

hereditary angioedema; polymorphism; ACE; MBL2; BDKR1; BDKR2; genotype; phenotype

Tags

International impact
Změněno: 11/4/2012 15:14, Mgr. Michal Petr

Abstract

V originále

Hereditary angiooedema (HAE) is a life-threatening disease with poor clinical phenotype correlation with its causal mutation in the C1 inhibitor (SERPING1) gene. It is characterized by substantial symptom variability even in affected members of the same family. Therefore, it is likely that genetic factors outside the SERPING1 gene have an influence on disease manifestation. In this study, functional polymorphisms in genes with a possible disease-modifying effect, B1 and B2 bradykinin receptors (BDKR1, BDKR2), angiotensin-converting enzyme (ACE) and mannose-binding lectin (MBL2), were analysed in 36 unrelated HAE patients. The same analysis was carried out in 69 HAE patients regardless of their familial relationship. No significant influence of the studied polymorphisms in the BDKR1, BDKR2, ACE and MBL2 genes on overall disease severity, localization and severity of particular attacks, frequency of oedema episodes or age of disease onset was detected in either group of patients. Other genetic and/or environmental factors should be considered to be responsible for HAE clinical variability in Caucasians.